Game-Changer for Tough Stomach Cancer

Big news for anyone following cancer breakthroughs: a new study just showed that Enhertu (T-DXd) can help people with aggressive HER2+ stomach or GEJ cancer live longer than the old chemo combo. It’s like a smart missile that targets cancer cells, and the results are so good, experts say it should be the new go-to after first treatments stop working. For families facing limited options, this could mean more time and real hope. #CancerResearch #GastricCancer #Enhertu #Health